Table 1.

Demographic and clinical characteristics of DM participants

Participant #	Age (years)	Menopausal age (years)	BMI (kg/m2)	DM duration (months)	A1c (%)	Total cholesterol (mg/dL)	Systole (mmHg)	Diastole (mmHg)
1	63	50	27.4	60	6.7	–	151	81
2	79	45	28.3	144	7.9	–	155	75
3*	65	50	40.7	120	7.1	–	145	97
4‡	66	50	29.3	186	8.7	199	111	62
5*	64	40	44.1	60	6.2	109	180	91
6	60	50	37.5	387	10.4	224	161	78
7*	60	55	33.7	245	8	143	130	70
8	57	49	36.9	41	8.6	176	130	88
9^	73	60	25.3	201	6.8	125	167	78
10	68	23	31.8	168	5.7	219	164	89
11	70	45	26.9	200	6.1	266	130	71
12	62	38	32.4	36	6.2	189	124	70
13	67	45	30.2	1	8	144	158	97
14*‡	66	45	31.4	262	6.3	175	142	75
15*	69	55	42.3	298	8.4	185	139	63
16	58	51	32.8	95	7.4	143	153	89
17*	55	27	38.6	385	7.4	126	133	68
18	67	25	30.5	1	7.7	183	148	73
19*^	71	52	42.9	196	8.5	173	105	60
20	69	27	36.3	149	8.7	187	202	100
21	60	37	30.1	1	6.7	183	179	111
Mean	65	43	33.8	154	7.5	175	148	80
SD	6	11	5.6	117	1.2	39	23	14
Controls	67 ± 6	50 ± 7	24.1 ± 4.5	N/A	5.3 ± 0.3	200 ± 43	147 ± 21	86 ± 14

^*Indicates a clinical diagnosis of diabetic peripheral neuropathy

^‡Indicates a history of Prempro Rx (in addition to 3 control participants); – Indicates lipid data collection failure; SD standard deviation

^{^}indicates omitted fNIRS data due to lack of reliable signal